136 related articles for article (PubMed ID: 3742454)
21. DNA flow cytometry of follicular non-Hodgkin's lymphoma.
Macartney JC; Camplejohn RS; Morris R; Hollowood K; Clarke D; Timothy A
J Clin Pathol; 1991 Mar; 44(3):215-8. PubMed ID: 2013622
[TBL] [Abstract][Full Text] [Related]
22. DNA content analysis of fine needle aspirates obtained from lymphatic tissue.
Alanen KA; Joensuu H; Klemi PJ
Anal Quant Cytol Histol; 1993 Aug; 15(4):259-64. PubMed ID: 8397647
[TBL] [Abstract][Full Text] [Related]
23. DNA content of T-cell lymphomas. A flow-cytometric analysis.
Egerter DA; Said JW; Epling S; Lee S
Am J Pathol; 1988 Feb; 130(2):326-34. PubMed ID: 3257649
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of non-Hodgkin's lymphoma probed by nucleic acid cytometry.
Srigley J; Barlogie B; Butler JJ; Osborne B; Blick M; Johnston D; Kantarjian H; Reuben J; Batsakis J; Freireich EJ
Blood; 1985 May; 65(5):1090-6. PubMed ID: 3995168
[TBL] [Abstract][Full Text] [Related]
25. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of DNA flow cytometry combined with fine needle aspiration biopsy in lymphomas.
Joensuu H; Klemi PJ; Eerola E
J Pathol; 1988 Mar; 154(3):237-45. PubMed ID: 3351670
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometric analysis of DNA ploidy in large cleaved cell lymphomas.
Aine R; Lehtinen T; Lehtinen M; Blanco G; Apaja-Sarkkinen M; Leinikki P; Alavaikko M
Hematol Oncol; 1990; 8(6):339-46. PubMed ID: 2286357
[TBL] [Abstract][Full Text] [Related]
28. Prognostic relevance of non-Hodgkin's lymphomas cell cycle data.
Vucković J; Forenpoher G; Marusić M; UZarević B; Zemunik T
Neoplasma; 1998; 45(5):332-5. PubMed ID: 9921923
[TBL] [Abstract][Full Text] [Related]
29. DNA ploidy patterns and cytokinetics of non-Hodgkin's lymphoma.
Juneja SK; Cooper IA; Hodgson GS; Wolf MM; Ding JC; Ironside PN; Thomas RJ; Parkin JD
J Clin Pathol; 1986 Sep; 39(9):987-92. PubMed ID: 3760241
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic, predictive and prognostic verification of DNA flow cytometric measurements performed at diagnosis for non-Hodgkin's lymphoma adult patients.
Lackowska B; Gruchała A; Jaszcz-Gruchała A; Rolski J; Zemełka T; Dańda D; Ryś J
Pol J Pathol; 2012 Mar; 63(1):18-24. PubMed ID: 22535602
[TBL] [Abstract][Full Text] [Related]
31. DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.
Cowan RA; Harris M; Jones M; Crowther D
Br J Cancer; 1989 Dec; 60(6):904-10. PubMed ID: 2605100
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma.
Rehn S; Glimelius B; Strang P; Sundström C; Tribukait B
Hematol Oncol; 1990; 8(1):1-12. PubMed ID: 2298418
[TBL] [Abstract][Full Text] [Related]
33. DNA content and kinetic characteristics of non-Hodgkin's lymphoma: determined by flow cytometry and autoradiography.
Costa A; Mazzini G; Del Bino G; Silvestrini R
Cytometry; 1981 Nov; 2(3):185-8. PubMed ID: 7297353
[TBL] [Abstract][Full Text] [Related]
34. Morphological and clinical significance of cell kinetics in non-Hodgkin's lymphomas.
Del Bino G; Silvestrini R; Costa A; Veneroni S; Giardini R
Basic Appl Histochem; 1986; 30(2):197-202. PubMed ID: 3741316
[TBL] [Abstract][Full Text] [Related]
35. Ploidy and proliferative activity measurement by flow cytometry in non-Hodgkin's lymphomas. Do speculative aspects prevail over clinical ones?
Cavalli C; Danova M; Gobbi PG; Riccardi A; Magrini U; Mazzini G; Bertoloni D; Rutigliano L; Rossi A; Ascari E
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1755-63. PubMed ID: 2632257
[TBL] [Abstract][Full Text] [Related]
36. Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study.
Lackowska B; Gruchała A; Niezabitowski A; Radkowski A; Skołyszewski J; Ryś J; Szklarski W; Sokołowski A
Pol J Pathol; 1999; 50(1):23-9. PubMed ID: 10412271
[TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
38. Pathological variables determining the prognosis of non-Hodgkin's lymphomas.
Kelly SA; Harkin PJ; Jack AS
Histopathology; 1992 Mar; 20(3):229-36. PubMed ID: 1563709
[TBL] [Abstract][Full Text] [Related]
39. [DNA--ploidy in non hodgkin's lymphomas of low malignancy].
Krygier-Stojałowska A; Urasiński I; Kuchnio M; Gapski Z
Acta Haematol Pol; 1993; 24(2):153-60. PubMed ID: 8372615
[TBL] [Abstract][Full Text] [Related]
40. Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67.
Gerdes J; Dallenbach F; Lennert K; Lemke H; Stein H
Hematol Oncol; 1984; 2(4):365-71. PubMed ID: 6396192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
